Sogroya 15 mg/1.5 mL solution for injection in pre-filled pen
Sponsors
Novo Nordisk A/S
Conditions
Children with short stature either born small for gestational age or with Turner syndromeGrowth Hormone Deficiency in childrenNoonan syndromeSGA - small for gestational age childrenor idiopathic short stature
Phase 2
Phase 3
A trial comparing the effect and safety of once weekly dosing of somapacitan with daily Norditropin® in children with growth hormone deficiency
CompletedCTIS2023-506829-11-00
Start: 2019-05-29End: 2025-09-30Target: 22Updated: 2025-10-31
A study comparing the effect and safety of once weekly dosing of somapacitan with daily Norditropin® as well as evaluating long-term safety of somapacitan in a basket study design in children with short stature either born small for gestational age or with Turner syndrome, Noonan syndrome, or idiopathic short stature
Active, not recruitingCTIS2023-506927-27-00
Start: 2022-08-29Target: 135Updated: 2025-10-27